Mexiletine as an adjuvant analgesic for the management of neuropathic cancer pain.
Sloan
P
P
Department of Anesthesiology, University of Kentucky, Lexington, USA. psloan@uky.campuscwix.net
Basta
M
M
Storey
P
P
von Gunten
C
C
D000230:Adenocarcinoma / Q000473:pathology / Q000503:physiopathology; D018712:Analgesics, Non-Narcotic / Q000009:adverse effects / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008160:Lumbosacral Plexus / Q000473:pathology / Q000503:physiopathology; D008175:Lung Neoplasms / Q000473:pathology / Q000503:physiopathology; D008801:Mexiletine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000473:pathology / Q000503:physiopathology*; D010147:Pain Measurement; D010148:Intractable Pain / Q000188:drug therapy* / Q000503:physiopathology; D014594:Uterine Neoplasms / Q000473:pathology / Q000503:physiopathology
D018712:Analgesics, Non-Narcotic; D008801:Mexiletine